The Need for Randomized Clinical Trials Demonstrating Reduction in All-Cause Mortality With Blood Tests for Cancer Screening. Read more about The Need for Randomized Clinical Trials Demonstrating Reduction in All-Cause Mortality With Blood Tests for Cancer Screening.
JAMA Network Call for Papers on Health and the 2024 US Election. Read more about JAMA Network Call for Papers on Health and the 2024 US Election.
Reducing the Risks of Nuclear War-The Role of Health Professionals. Read more about Reducing the Risks of Nuclear War-The Role of Health Professionals.
Hospital Culture and Intensity of End-of-Life Care at 3 Academic Medical Centers. Read more about Hospital Culture and Intensity of End-of-Life Care at 3 Academic Medical Centers.
Association of Life Expectancy With Surveillance Colonoscopy Findings and Follow-up Recommendations in Older Adults. Read more about Association of Life Expectancy With Surveillance Colonoscopy Findings and Follow-up Recommendations in Older Adults.
A Polygenic Risk Score for Prostate Cancer Risk Prediction. Read more about A Polygenic Risk Score for Prostate Cancer Risk Prediction.
Excess Mortality Among US Physicians During the COVID-19 Pandemic. Read more about Excess Mortality Among US Physicians During the COVID-19 Pandemic.
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. Read more about Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.
Effect of COVID-19 Vaccine Messaging Platforms in Emergency Departments on Vaccine Acceptance and Uptake: A Cluster Randomized Clinical Trial. Read more about Effect of COVID-19 Vaccine Messaging Platforms in Emergency Departments on Vaccine Acceptance and Uptake: A Cluster Randomized Clinical Trial.
Use Trends and Recent Expenditures for Cervical Cancer Screening-Associated Services in Medicare Fee-for-Service Beneficiaries Older Than 65 Years. Read more about Use Trends and Recent Expenditures for Cervical Cancer Screening-Associated Services in Medicare Fee-for-Service Beneficiaries Older Than 65 Years.
